|Title:||8-Chloro-1-methyl-6-(O-chlo rophenyl)-4H-s-triazolo[4,3-a]-[1,4]benzodiazepine compositions and method of treatment|
|Abstract:||Therapeutic compositions for treating humans and animals comprising, in dosage unit form, a 8-chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepi ne compound of the formula ##SPC1## Including the N-oxides and pharmacologically acceptable acid addition salts thereof in combination with a pharmaceutical carrier. The compositions are useful as soporifics and provide a process for inducing sleep.|
|Inventor(s):||Hester, Jr.; Jackson B. (Galesburg, MI)|
|Assignee:||The Upjohn Company (Kalamazoo, MI)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Dosage form; Process;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.